AD Pharma SRL
AD Pharma reported total assets of €1.37m at the end of the 2025 financial year (annual accounts filed with the NBB on 02 Jul 2026).
The score of AD Pharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +289 % Total assets +408 %
Accounts of the company itself (not consolidated).
The full file covers 6 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
AD Pharma's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 02 Jul 2026
- Year ended 31 Dec 2024filed on 20 Aug 2025
- Year ended 31 Dec 2023filed on 21 Aug 2024
- Year ended 31 Dec 2022filed on 29 Jun 2023
- Year ended 31 Dec 2021filed on 30 Jun 2022
AD Pharma's financial analysis
- Solvency8.6%sector median: 40.1%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of AD Pharma
AD Pharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0736.833.279
- VAT number
- BE0736833279
- Peppol
- Registered · 0208:0736833279 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 28 Oct 2019
- Registered office
- 6200 Châtelet
- Latest accounts
- 2025 · filed on 02 Jul 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
AD Pharma (SRL) has been based in Châtelet since 2019, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 88,132 € and equity of 118,742 €; its revenue is not published. Its solvency stands at 8.6%, below the median of its sector (40.1%).
Companies similar to AD Pharma
Companies in the same business, of comparable size and area, outside its group.
- Pharmacie DU Perron Châtelet Retail sale of pharmaceutical products Charleroi · balance sheet €1.28m
- DE Spiegeleere - Discart Retail sale of pharmaceutical products Braine-l'Alleud · balance sheet €1.36m
- Decopharma Retail sale of pharmaceutical products Sint-Niklaas · balance sheet €1.36m
- Geerts Farma Retail sale of pharmaceutical products Vilvoorde · balance sheet €1.38m
- Apogrez Retail sale of pharmaceutical products Grez-Doiceau · balance sheet €1.37m
- EVDW Retail sale of pharmaceutical products Ghent · balance sheet €1.38m
- Mast & CO Retail sale of pharmaceutical products Merchtem · balance sheet €1.36m
- Apotheek Zuiderkruis Retail sale of pharmaceutical products Antwerp · balance sheet €1.35m
Frequently asked questions about AD Pharma
What is the revenue of AD Pharma?
AD Pharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of AD Pharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0736833279 for AD Pharma, if the company is VAT-registered. Its company number (CBE) is 0736.833.279.
Where is the registered office of AD Pharma?
According to the CBE register, the registered office of AD Pharma is in 6200 Châtelet.
What is the equity of AD Pharma?
At the close of the 2025 financial year, the equity of AD Pharma amounts to 118,742 €, a solvency of 8.6% of total assets.
Who manages AD Pharma?
The register lists 1 active mandates at AD Pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of AD Pharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →